Accelerating development of engineered T cell therapies in the EU: current regulatory framework for studying multiple product versions and T2EVOLVE recommendations
加速欧盟工程化T细胞疗法的研发：当前研究多种产品版本的监管框架及T2EVOLVE建议
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2023.1280826
Ammar, Delphine; Schapitz, Inga; Luu, Maik; Hudecek, Michael; Meyer, Miriam; Taps, Timmothy; Schröder, Bernd; Ivics, Zoltán; Sanges, Carmen; Franz, Paul; Koehl, Ulrike; Negre, Helene; Johanna, Inez; Awigena-Cook, Jacquelyn
